343 related articles for article (PubMed ID: 33557879)
1. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data.
Zhong Q; Lu M; Yuan W; Cui Y; Ouyang H; Fan Y; Wang Z; Wu C; Qiao J; Hang J
J Transl Med; 2021 Feb; 19(1):58. PubMed ID: 33557879
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of prognostic long non-coding RNAs with copy number variation in bladder cancer.
Zhong W; Wang D; Yao B; Chen X; Wang Z; Qu H; Ma B; Ye L; Qiu J
J Zhejiang Univ Sci B; 2021 Aug; 22(8):664-681. PubMed ID: 34414701
[TBL] [Abstract][Full Text] [Related]
3. Copy number variations primed lncRNAs deregulation contribute to poor prognosis in colorectal cancer.
Liu H; Gu X; Wang G; Huang Y; Ju S; Huang J; Wang X
Aging (Albany NY); 2019 Aug; 11(16):6089-6108. PubMed ID: 31442207
[TBL] [Abstract][Full Text] [Related]
4. Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
Zheng M; Hu Y; Gou R; Nie X; Li X; Liu J; Lin B
Biomed Pharmacother; 2020 Apr; 124():109810. PubMed ID: 32000042
[TBL] [Abstract][Full Text] [Related]
5. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
6. Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.
Wang R; Li Y; Du P; Zhang X; Li X; Cheng G
Life Sci; 2019 Sep; 233():116708. PubMed ID: 31369759
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia.
James AR; Schroeder MP; Neumann M; Bastian L; Eckert C; Gökbuget N; Tanchez JO; Schlee C; Isaakidis K; Schwartz S; Burmeister T; von Stackelberg A; Rieger MA; Göllner S; Horstman M; Schrappe M; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Akalin A; Baldus CD
J Hematol Oncol; 2019 Jan; 12(1):8. PubMed ID: 30642353
[TBL] [Abstract][Full Text] [Related]
8. Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.
Xu Z; Chen H; Sun J; Mao W; Chen S; Chen M
Bioengineered; 2021 Dec; 12(2):11108-11125. PubMed ID: 34738881
[TBL] [Abstract][Full Text] [Related]
9. The transcriptome profiles and methylation status revealed the potential cancer-related lncRNAs in patients with cervical cancer.
Yuan LY; Qin X; Li L; Zhou J; Zhou M; Li X; Xu Y; Wang XJ; Xing H
J Cell Physiol; 2019 Jun; 234(6):9756-9763. PubMed ID: 30362566
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
[TBL] [Abstract][Full Text] [Related]
11. Identification of a six lncRNAs signature as novel diagnostic biomarkers for cervical cancer.
Luo W; Wang M; Liu J; Cui X; Wang H
J Cell Physiol; 2020 Feb; 235(2):993-1000. PubMed ID: 31332778
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide transcriptomics and copy number profiling identify patient-specific CNV-lncRNA-mRNA regulatory triplets in colorectal cancer.
Liu T; Liu Y; Su X; Peng L; Chen J; Xing P; Qiao X; Wang Z; Di J; Zhao M; Jiang B; Qu H
Comput Biol Med; 2023 Feb; 153():106545. PubMed ID: 36646024
[TBL] [Abstract][Full Text] [Related]
13. Identification of Three Prognosis-Related Differentially Expressed lncRNAs Driven by Copy Number Variation in Thyroid Cancer.
Tian J; Luo B
J Immunol Res; 2022; 2022():9203796. PubMed ID: 35642209
[TBL] [Abstract][Full Text] [Related]
14. Identification and comprehensive characterization of lncRNAs with copy number variations and their driving transcriptional perturbed subpathways reveal functional significance for cancer.
Xu Y; Wu T; Li F; Dong Q; Wang J; Shang D; Xu Y; Zhang C; Dou Y; Hu C; Yang H; Zheng X; Zhang Y; Wang L; Li X
Brief Bioinform; 2020 Dec; 21(6):2153-2166. PubMed ID: 31792500
[TBL] [Abstract][Full Text] [Related]
15. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers.
Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ
J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162
[TBL] [Abstract][Full Text] [Related]
16. Multi-omics approach for identifying CNV-associated lncRNA signatures with prognostic value in prostate cancer.
Tyagi N; Roy S; Vengadesan K; Gupta D
Noncoding RNA Res; 2024 Mar; 9(1):66-75. PubMed ID: 38075203
[TBL] [Abstract][Full Text] [Related]
17. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
Gong Z; Hong F; Wang H; Zhang X; Chen J
BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434
[TBL] [Abstract][Full Text] [Related]
18. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
Li M; Long S; Hu J; Wang Z; Geng C; Ou S
Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451
[TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
20. Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data.
Zhao H; Zhang S; Yin X; Zhang C; Wang L; Liu K; Xu H; Liu W; Bo L; Lin S; Feng K; Lin L; Fei M; Ning S; Wang L
Front Immunol; 2022; 13():990143. PubMed ID: 36304471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
